You're reading the free version. Trader adds the live tape and alerts.
Start tracking
URGN Exercise Disclosure
Degnan Chris · SEC Form 4 · Filed Oct 9, 2026
Exercise
Reported value range
Not reported
Degnan Chris Chief Financial Officer
URGN
UroGen Pharma Ltd
URGN
Transaction date
Oct 8, 2026
Public filing date
Oct 9, 2026
Filing lag
Filed 1 day later
URGN daily price context
Close on/before transaction
$36.98
Oct 8, 2026
First close after public filing
$36.83
Oct 9, 2026
30-day return after filing
-28.56%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 4,483 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-032421
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$80.79K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Urogen Pharma Ltd. URGN | Sale | Oct 8, 2026 | $80.79K |
| Urogen Pharma Ltd. URGN | Exercise | Oct 8, 2026 | $0 |
| Urogen Pharma Ltd. URGN Current | Exercise | Oct 8, 2026 | Not reported |